Unique step-wise dosing with Jivi®, with the potential for fewer infusions1,2

Study Design Chart
  • 100% of patients in the every-5-days and twice-weekly dosing arms remained on the same dosing regimen for the duration of the main study.1
  • n=40/47 patients in the every-5-days and twice-weekly dosing arms for whom prior prophylaxis dosing records were available.3